NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country UPV/EHU, School of Pharmacy, Vitoria- Gasteiz. Spain.
Laboratory of Pharmaceutics, University of the Basque Country UPV/EHU, School of Pharmacy, Vitoria- Gasteiz. Spain.
Curr Pharm Des. 2017;23(24):3567-3584. doi: 10.2174/0929867324666170511123101.
Tissue engineering is considered one of the most important therapeutic strategies of regenerative medicine. The main objective of these new technologies is the development of substitutes made with biomaterials that are able to heal, repair or regenerate injured or diseased tissues and organs. These constructs seek to unlock the limited ability of human tissues and organs to regenerate. In this review, we highlight the convenient intrinsic properties of gelatin for the design and development of advanced systems for tissue engineering. Gelatin is a natural origin protein derived from collagen hydrolysis. We outline herein a state of the art of gelatin-based composites in order to overcome limitations of this polymeric material and modulate the properties of the formulations. Control release of bioactive molecules, formulations with conductive properties or systems with improved mechanical properties can be obtained using gelatin composites. Many studies have found that the use of calcium phosphate ceramics and diverse synthetic polymers in combination with gelatin improve the mechanical properties of the structures. On the other hand, polyaniline and carbon-based nanosubstrates are interesting molecules to provide gelatin-based systems with conductive properties, especially for cardiac and nerve tissue engineering. Finally, this review provides an overview of the different types of gelatin-based structures including nanoparticles, microparticles, 3D scaffolds, electrospun nanofibers and in situ gelling formulations. Thanks to the significant progress that has already been made, along with others that will be achieved in a near future, the safe and effective clinical implementation of gelatin-based products is expected to accelerate and expand shortly.
组织工程被认为是再生医学中最重要的治疗策略之一。这些新技术的主要目标是开发使用生物材料制成的替代品,这些材料能够治愈、修复或再生受伤或患病的组织和器官。这些构建体旨在释放人体组织和器官再生的有限能力。在这篇综述中,我们强调了明胶在设计和开发先进组织工程系统方面的便利固有特性。明胶是一种天然来源的蛋白质,源自胶原蛋白水解。我们概述了基于明胶的复合材料的最新技术,以克服这种聚合物材料的局限性并调节配方的性能。可以使用明胶复合材料来实现生物活性分子的控制释放、具有导电性的制剂或具有改善的机械性能的系统。许多研究发现,将磷酸钙陶瓷和各种合成聚合物与明胶结合使用可以改善结构的机械性能。另一方面,聚苯胺和基于碳的纳米基质是为基于明胶的系统提供导电性的有趣分子,特别是对于心脏和神经组织工程。最后,本综述概述了不同类型的基于明胶的结构,包括纳米粒子、微粒子、3D 支架、电纺纳米纤维和原位凝胶制剂。由于已经取得了重大进展,以及未来即将取得的其他进展,预计基于明胶的产品的安全有效临床应用将很快加速和扩大。